Genetic suppressors as new therapeutic targets for Mendelian diseases.

Genetic suppressors could provide new therapeutic targets for Mendelian diseases, with potential to counteract disease-causing mutations and improve treatment outcomes.

• Why it matters: Most Mendelian diseases currently lack treatments that address their genetic root causes, highlighting a critical need for innovative therapeutic strategies.
• What they did: The authors review the prevalence of suppressors, outline systematic identification methods, and discuss their therapeutic potential, emphasizing advances in genome-wide screening and machine learning.
• The result: Identifying genetic suppressors offers promising avenues for developing targeted therapies, potentially transforming care for individuals with inherited disorders.